FIELD: progestative agent. SUBSTANCE: derivative of 19-norprogesterone has formula 1 where R1 is H, methoxymethyl, tetrahydropyranyl, radical having formula 2, acyl C1-C6. Desired product yield is 14-88% , melting point is 76-237 C. 3-alkoxy-extra-1,3-triene is used as reagent 1, bromide of propyltriphenylphosphonium is used as reagent 2, 3-alkoxy-12- propylidenextra 1, 3, 3, (10) triene is used as reagent 3. Li in liquid NH3 is used as reagent 4; 3-oxo-21-methyl-19-norpregnane 4,17(20)diene is used as reagent 5; trialkylorthoformiate together with acid are used as reagent 6; 3-alkoxy-17- propylidene-extra-3,5-diene is used as reagent 7; POCl+ dimethylformamide is used as reagent 8. 3-alkoxy-6-formyl-21- methyl-19-norpregnatriene-3,5,17 (20) is used as reagent 9; mixed hydride of alkali metal is used as reagent 10; 6-hydroxymethyl-21- methyl-3-oxo-19-norpregna-4,17 (20)-diene is used as reagent 11. Hydrochloric acid HCl is used as reagent 12; 21-methyl-6-methylene- 3-oxo-19-norpregna-4,17 (20)-diene is used as reagent 13; Pd/C+C2H5OH+CH3COONa is as reagent 14. 3-oxo-6-methylextra-4,6-diene is used as reagent 15. OSO+ N-oxidetriethylamine hydroxide are used as reagent 16, 17-hydroxy-6,21- dimethyl-3,20-dioxo-19-norpregna-4,6-diene is used as reagent 17. If it is necessary reaction is followed by methoxymethylation, dihydropiranylation or by acylation. Formulae 1 and 2 are given in specification. EFFECT: improves efficiency of the method.
Title |
Year |
Author |
Number |
DERIVATIVES OF 19-NORPREGNENE, PHARMACEUTICAL COMPOSITION, COMPOUNDS |
1997 |
- Alan Piasko
- Zhan Ljafaj
- Remi Delansorn
- Zhak Pari
- Zhan-Klod Paskal'
|
RU2166509C2 |
NEW COMPOSITIONS AS SUBCUTANEOUS IMPLANTS BASED ON NORMEGESTROL DERIVATIVES, METHOD OF THEIR SYNTHESIS AND USING |
1993 |
- Mishel' Lanketen
- Zhan Lui Toma
- Zhak Pari
- Ehl'Simar Kutino
|
RU2120797C1 |
MICROCRYSTALS, METHOD OF PREPARING MICROCRYSTALS, AND PHARMACEUTICAL COMPOSITION |
1991 |
|
RU2126013C1 |
HORMONAL OR NON-HORMONAL STEROID COMPOUNDS, METHOD FOR THERAPEUTIC TREATMENT |
1999 |
- Kuk K. Ehdgar
- Kepler Dzhon A.
- O`Rejli Dzhill M.
|
RU2230071C2 |
19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS |
1993 |
- Ehkkhard Ottov
- Vol'Fgang Shvede
- Vol'Fgang Khal'Fbrodt
- Karl-Khajnrikh Frittsemajer
- Rol'F Krattenmakher
|
RU2157814C2 |
METHOD FOR OBTAINING 17- ALKYLATED 6-METHYL-19-NORPREGNA-4,6-DIENES AND INTERMEDIATE COMPOUNDS OF THIS SYNTHESIS |
0 |
- Klod Chernatinskij
- Nedzhib Mokhamed Nasraui
|
SU1836379A3 |
STEROID WITH 17-SPIROMETHYLENELACTONE GROUP AND METHOD OF ITS SYNTHESIS |
1995 |
- Jokhannes Antonius Marija Khamersma
- Jap Van Der Lau
|
RU2168516C2 |
14,17-C-BRIDGE STEROIDS AND PHARMACEUTICAL PREPARATION |
1995 |
- Shell'Kopf Klaus
- Khal'Fbrodt Vol'Fgang
- Kunke Joakhim
- Shvede Vol'Fgang
- Frittsemajer Karl-Khajnrikh
- Krattenmakher Rol'F
- Mun Khans-Peter
|
RU2169153C2 |
DERIVATIVES OF 11,21-BISPHENYL-19-NORPREGNANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING |
1995 |
- Gebkhar Ronal'D
- Van Der Vort Khendrikus Adrianus Antonius
|
RU2152952C2 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION |
2000 |
- Lejsen Dirk
- Van Der Lau Jap
- Buma Bursi Roberta
- De Gojer Marsel' Ehvert
|
RU2242479C2 |